First-line treatment options for advanced gastric/gastroesophageal junction cancer patients with PD-L1-positive: a systematic review and meta-analysis.

导出 LinkOut

翻译打印收藏纠错

第一作者： Ling,Fan

第一单位： Department of Gastroenterology, The First Affiliated Hospital of Xi'an Medical University.

作者： Ling,Fan ^[1] ; Ning,Lu ^[1] ; Lingmin,Zhang ^[2] ; Jie,Zhang ^[1] ; Jie,Li ^[1] ; Manli,Cui ^[1] ; Mingxin,Zhang ^[1]

作者单位： Department of Gastroenterology, The First Affiliated Hospital of Xi'an Medical University. ^[1] Department of Anesthesiology, First Affiliated Hospital, Xi'an Jiaotong University, Xi'an. ^[2] Shaanxi University of Traditional Chinese Medicine, Xianyang, Shaanxi, China. ^[3]

关键词 Immune checkpoint inhibitors PD-1 inhibitors advanced GC/GEJC meta-analysis

DOI 10.1097/MS9.0000000000000765

PMID 37363517

发布时间 2023-07-01

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Annals of medicine and surgery (2012)

2023年85卷6期

2875-2883页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

First-line treatment options for advanced gastric/gastroesophageal junction cancer patients with PD-L1-positive: a systematic review and meta-analysis.

Annals of medicine and surgery (2012)

相似文献

Annals of medicine and surgery (2012)

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

First-line treatment options for advanced gastric/gastroesophageal junction cancer patients with PD-L1-positive: a systematic review and meta-analysis.

Annals of medicine and surgery (2012)

相似文献

Annals of medicine and surgery (2012)

相关期刊

检索历史清除